SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Novartis India informs about issuance of duplicate share certificate

21 Dec 2023 Evaluate

Novartis India has informed that it enclosed intimation dated December 21, 2023 received from Link Intime India, Registrar and Transfer Agent, providing information regarding issue of duplicate share certificate in favour of shareholder of the Company. Further, in accordance with the SEBI Notification No. SEBI/LAD-NRO/GN/2022/66 dated January 24, 2022, read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, letter of confirmations in lieu of the physical share certificate will be issued to the said shareholder of the Company within the prescribed timelines.

The above information is a part of company’s filings submitted to BSE.

Novartis Share Price

1000.55 9.25 (0.93%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 220.95
Adani Enterprises 2088.20
Amrapali Industries 17.32
Rashi Peripheral 404.30
PDS 295.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×